Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
All Genders
Healthy Volunteers
ID05903885

Using a Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

Led by University of Nebraska · Updated on 2026-02-10

1200

Participants Needed

2

Research Sites

17 weeks

Total Duration

On this page

Sponsors

U

University of Nebraska

Lead Sponsor

R

Robert Wood Johnson Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are addressing racial disparities in colorectal cancer (CRC) by focusing on African Americans aged 45 to 75, who face higher CRC incidence and mortality and lower screening rates. The study aims to improve CRC screening by partnering with the Department of Motor Vehicles (DMV) to recruit 1,200 African American participants during their DMV visits. The research compares two approaches to increase screening: on-site distribution of Fecal Immunochemical Test (FIT) kits and on-site distribution combined with targeted social media advertising. Participants will receive a free FIT kit with a prepaid return envelope, a culturally tailored educational brochure, reminder text messages, and phone calls. The social media group will see targeted ads on Facebook, Instagram, and YouTube from August to October 2024. Participants return kits to a Nebraska Medicine lab, and results are mailed within 14 to 21 days. For those with positive results or lacking insurance or a primary care provider, a health navigator provides help with scheduling follow-up colonoscopies and accessing financial support. Throughout the study, participants provide demographic and screening information via surveys. Researchers measure FIT kit return rates, positive test rates, and follow-up colonoscopy completion rates, comparing the two groups while considering factors like age, gender, income, and health beliefs. Participants' perceptions about screening are also gathered through an online survey. The study runs until October 2026, with ongoing monitoring of screening completion and follow-up outcomes.

CONDITIONS

Brief Title

A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

Who Can Participate

Age: 45Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Self-identify as Black or African American
  • Aged between 45 and 75 years
  • Not up-to-date with colorectal cancer screening per guidelines
  • Willing to provide contact information for follow-up
  • Able to speak, read, and write English
  • Currently living in Douglas County, Nebraska
Not Eligible

You will not qualify if you...

  • History of colorectal cancer
  • History of adenomas (precancerous polyps) or inflammatory bowel disease
  • Family history of colorectal cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) during a regular DMV visit

Treatment

Duration - Up to 6 months from the date of FIT kit distribution

Participants receive a Fecal Immunochemical Test (FIT) kit at the Department of Motor Vehicles (DMV) and are guided by research staff on how to use it. They also receive a culturally tailored educational brochure, reminder text messages, and phone calls within 3 weeks to encourage kit return. One group is additionally exposed to targeted social media advertisements to increase awareness about colorectal cancer screening.

1 visit at the DMV for kit distribution; reminders via text and phone calls within 3 weeks; kit returned by mail

Follow-up

Duration - Up to 6 months from the date of positive FIT result notification

Participants with positive FIT results or without health insurance or a primary care provider receive follow-up support from a health navigator to assist with scheduling colonoscopies and accessing financial support programs.

Follow-up support contacts as needed; colonoscopy appointments as arranged

Trial Site Locations

Total: 2 locations

1

Department of Motor Vehicles (DMV)

Omaha, Nebraska, United States, 68104

Actively Recruiting

2

Douglas County Treasurer's Office

Omaha, Nebraska, United States, 68104

Actively Recruiting

Loading map...

Research Team

J

Jungyoon Kim, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.

Christopher T Chen, Ling Li, Gabriel Brooks...

https://pubmed.ncbi.nlm.nih.gov/28748564

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Evelyn P Whitlock, Jennifer S Lin, Elizabeth Liles...

https://pubmed.ncbi.nlm.nih.gov/18838718

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Kirsten Bibbins-Domingo, David C Grossman...

https://pubmed.ncbi.nlm.nih.gov/27304597

Creating and Implementing a National Public Health Campaign: The American Cancer Society's and National Colorectal Cancer Roundtable's 80% by 2018 Initiative.

Richard C Wender, Mary Doroshenk, Durado Brooks...

https://pubmed.ncbi.nlm.nih.gov/30413821